Occlusion devices are used to treat several defects and medical conditions like closing of a blood vessel, blockage, and hallow organs. They are extensively used to treat cardiac defects like blockages in coronary arteries and also widely used in gynecology, oncology, urology, neurology, and others. In cardiology, the occlusion devices are majorly used for left Atrial Appendage (LAA). According to researchers, these devices reduce the risk of stroke with AFib and can be an ideal substitute for patients who do not wish for or are unable to long term anticoagulation treatment. Threes devices are upgraded developed and approved and are expected to witness higher demand in the near future.
Major Key Players of the Occlusion Devices Market are:Abbott, Cardinal Health, Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, BD, ASAHI INTECC CO., LTD., BVM Medical Limited, Acrostak Int., Cook, and others.
No comments:
Post a Comment